Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 2,607,000 | 2,215,000 | 26,866,500 | 2,557,700 | 2,559,890 |
| Cost of Goods | 632,000 | 570,000 | 8,784,000 | 883,080 | 899,130 |
| Gross Profit | 1,975,000 | 1,645,000 | 18,082,500 | 1,674,620 | 1,660,750 |
| Operating Expenses | 1,444,000 | 1,382,000 | 14,982,000 | 1,213,210 | 1,250,210 |
| Operating Income | 531,000 | 263,000 | 3,100,500 | 461,490 | 410,680 |
| Interest Expense | 45,000 | 54,000 | 273,000 | 49,840 | 59,720 |
| Other Income | 120,000 | 243,000 | 2,782,500 | 65,990 | 82,940 |
| Pre-tax Income | 606,000 | 452,000 | 5,610,000 | 477,640 | 433,900 |
| Income Tax | 219,000 | 182,000 | 2,005,500 | 143,500 | 124,780 |
| Net Income Continuous | 387,000 | 345,737 | 364,874 | 317,864 | 276,326 |
| Net Income | $387,000 | $270,000 | $3,613,500 | $334,130 | $309,630 |
| EPS Basic Total Ops | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 |
| EPS Basic Continuous Ops | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 |
| EPS Diluted Total Ops | N/A | 0.05 | 0.05 | 0.04 | 0.04 |
| EPS Diluted Continuous Ops | N/A | 0.05 | 0.05 | 0.04 | 0.04 |
| EBITDA(a) | $531,000 | $263,000 | $3,100,500 | $461,490 | $410,680 |